Positive correlation between rivaroxaban plasma levels and measures of thrombin generation. Positive correlation between rivaroxaban plasma levels and ETP (A) and thrombin peak (B) reduction at 15-, 20-, 22.5-, and 30-mg doses as measured by a TG assay.